Contact :+27(0) 74 885 5577

According to a recent study it was found that untreated severe obstructive sleep apnea (OSA) is associated with increased aggressiveness of malignant cutaneous melanoma. This was the conclusion after a multi-center prospective study on the relationship between sleep-disordered breathing and cancer.

Researchers from 24 Hospitals that form part of the Spanish Sleep and Breathing Network, took part in this study. The findings were presented at the American Thoracic Society (ATS) 2016 International Conference.

Lead author, Miguel Ángel Martinez-Garcia, MD, PhD, from the Hospital Universitario y Politécnico La Fe, Valencia, Spain, stated in a release.“This is the first large prospective multi-center study that was specifically constructed to look at the relationship between sleep apnea and a specific cancer. While more research is needed, this study shows that patients in the study had markers of poor prognosis for their melanoma. It also highlights the importance of diagnosing and treating sleep apnea.”

The study involved 412 patients, average age 55.8, with confirmed cases of cutaneous malignant melanoma. The number of men and women in the study group was approximately equal. Martinez-Garcia and colleagues looked at a number of factors that indicated patients’ prognosis, including the Clark and Breslow indices, which, taken together, determine the stage of melanoma.

All patients underwent a sleep study, and patients previously treated with CPAP, were excluded. It was found that patients diagnosed with the most aggressive cancers had higher prevalence and severity of obstructive sleep apnea. This relationship held true independent of age, gender, body mass index, skin type, sun exposure, and other risk factors for melanoma.

“The relationship between sleep apnea and heart disease, as well as with automotive accidents, is already well established,” says Martinez-Garcia in a release. “Based on our study, it seems a relationship between sleep apnea and cancer may also exist. It is very important, however, that people with sleep apnea do not infer that they will necessarily develop cancer.”

The reason for focusing the study on melanoma was the following. Cutaneous melanoma can be easily observed and measured, and its aggressiveness determined using well-validated measures such as the Clark and Breslow indices. Members of the study group have also published a growth rate index for melanoma. In addition, earlier animal studies showed a link between melanoma growth and sleep apnea.

“Our findings have implications for both patients and physicians,” Martinez-Garcia adds. “People who snore, frequently wake up at night, or have daytime sleepiness should see a sleep specialist, especially if they have other risk factors for cancer or already have cancer. Physicians—especially dermatologists, cancer surgeons, and medical oncologists—should ask their patients about potential sleep apnea symptoms, and refer them for a sleep study if they have these symptoms.”

Martinez-Garcia and colleagues plan additional research on this topic. The first study will examine these patients over time, in order to analyze other important variables such as melanoma relapse, mortality, resistance to treatment, development of a second melanoma or other cancers, and metastasis, including spread of the cancer to nearby lymph nodes (sentinel nodes). He also plans a multicenter/multinational study of patients with melanoma or other types of cancer, to examine the effect of long-term CPAP therapy on those also diagnosed with sleep apnea.